The cytokine storm of COVID-19: a spotlight on prevention and protection

Convalescent plasma as a potential therapy for COVID-19

(2020) Long Chen et al.   LANCET INFECTIOUS DISEASES

A Novel Coronavirus from Patients with Pneumonia in China, 2019

(2020) Na Zhu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

(2020) Jasper Fuk-Woo Chan et al.   Emerging Microbes & Infections

Current Status of Septic Cardiomyopathy: Basic Science and Clinical Progress

(2020) Huan Lin et al.   Frontiers in Pharmacology

Coronavirus epidemic: preparing for extracorporeal organ support in intensive care

(2020) Claudio Ronco et al.   Lancet Respiratory Medicine

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions

(2020) Yvan Jamilloux et al.   AUTOIMMUNITY REVIEWS

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence

(2020) Julien Poissy et al.   CIRCULATION

Cytokine storm intervention in the early stages of COVID-19 pneumonia

(2020) Xinjuan Sun et al.   CYTOKINE & GROWTH FACTOR REVIEWS

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

(2020) Alaide Chieffo et al.   EUROPEAN HEART JOURNAL

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

(2020) Chi Zhang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

(2020) Eli S. Rosenberg et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

SARS-CoV-2: a storm is raging

(2020) Savannah F. Pedersen et al.   JOURNAL OF CLINICAL INVESTIGATION

Tocilizumab treatment in COVID-19: A single center experience

(2020) Pan Luo et al.   JOURNAL OF MEDICAL VIROLOGY

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

(2020) Yeming Wang et al.   LANCET

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

COVID-19: consider cytokine storm syndromes and immunosuppression

(2020) Puja Mehta et al.   LANCET

Kidney involvement in COVID-19 and rationale for extracorporeal therapies

(2020) Claudio Ronco et al.   Nature Reviews Nephrology

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

(2020) Thomas J. Oxley et al.   NEW ENGLAND JOURNAL OF MEDICINE

NKT Cells Join the Two Step for Inflammasome-Independent IL-1β Release

(2020) Jelena S. Bezbradica et al.   Cell Reports

Caution in the management of SARS‐CoV‐2 infection in males

(2020) Luca De Toni et al.   Andrology

Type I astrocytes and microglia induce a cytokine response in an encephalitic murine coronavirus infection

(2020) Ehud Lavi et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

(2019) Derek J Hausenloy et al.   LANCET

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

(2019) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

ROCK Inhibition Drives Resolution of Acute Inflammation by Enhancing Neutrophil Apoptosis

(2019) Izabela Galvão et al.   Cells

Rho signaling research: history, current status and future directions

(2018) Shuh Narumiya et al.   FEBS LETTERS

Regulatory T Cells and Acute Lung Injury: Cytokines, Uncontrolled Inflammation, and Therapeutic Implications

(2018) Shihui Lin et al.   Frontiers in Immunology

Restoring Self-tolerance in Autoimmune Diseases by Enhancing Regulatory T-cells

(2018) Prabhakaran Kumar et al.   CELLULAR IMMUNOLOGY

cGAS and STING: At the intersection of DNA and RNA virus-sensing networks

(2018) Guoxin Ni et al.   PLoS Pathogens

Endothelial cell activation in central nervous system inflammation

(2017) Fengjiao Wu et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Survival benefits of remote ischemic conditioning in sepsis

(2017) Bellal Joseph et al.   JOURNAL OF SURGICAL RESEARCH

Ischaemic conditioning and reperfusion injury

(2016) Derek J. Hausenloy et al.   Nature Reviews Cardiology

NOD-Like Receptors in Infection, Immunity, and Diseases

(2016) Young Keun Kim et al.   YONSEI MEDICAL JOURNAL

Molecular mechanisms of Ebola virus pathogenesis: focus on cell death

(2015) L Falasca et al.   CELL DEATH AND DIFFERENTIATION

IL-6 in Inflammation, Immunity, and Disease

(2014) T. Tanaka et al.   Cold Spring Harbor Perspectives in Biology

Adjuvant Treatment With a Mammalian Target of Rapamycin Inhibitor, Sirolimus, and Steroids Improves Outcomes in Patients With Severe H1N1 Pneumonia and Acute Respiratory Failure*

(2013) Chun-Hua Wang et al.   CRITICAL CARE MEDICINE

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

(2011) Christian Brun-Buisson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The effect of heparin administration in animal models of sepsis: A prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies*

(2011) Yan Li et al.   CRITICAL CARE MEDICINE

The immune system in atherosclerosis

(2011) Göran K Hansson et al.   NATURE IMMUNOLOGY

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

(2009) Satish L. Deshmane et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH